Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
Annales De Biologie Clinique|February 26, 2019
[Factor IX assays in treated hemophilia B patients]Claire Pouplard, Emmanuelle Jeanpierre, Dominique Lasne, et al.Journal of Thrombosis and Haemostasis : JTH|July 20, 2023
Imlifidase, a new option to optimize the management of patients with hemophilia A on emicizumabMelissa Bou-Jaoudeh, Angelina Mimoun, Sandrine Delignat, et al.Clinical Medicine Insights. Blood Disorders|December 17, 2014
Risk factors for thrombosis in an african populationAwa Ot Fall, Valérie Proulle, Abibatou Sall, et al.European Journal of Haematology|April 12, 2020
Factor VIII and IX assays for post-infusion monitoring in hemophilia patients: Guidelines from the French BIMHO group (GFHT)Emmanuelle Jeanpierre, Claire Pouplard, Dominique Lasne, et al.Blood Transfusion = Trasfusione Del Sangue|December 2, 2020
Effectiveness and safety of hFVIII/VWF concentrate (Voncento®) in patients with inherited von Willebrand disease requiring surgical procedures: the OPALE multicentre observational studyLucia Rugeri, Roseline d'Oiron, Annie Harroche, et al.Journal of Thrombosis and Haemostasis : JTH|June 4, 2023
Transplacental delivery of therapeutic proteins by engineered immunoglobulin G: a step toward perinatal replacement therapyAngelina Mimoun, Melissa Bou-Jaoudeh, Sandrine Delignat, et al.JCI Insight|October 14, 2016
LIM kinase/cofilin dysregulation promotes macrothrombocytopenia in severe von Willebrand disease-type 2BAlexandre Kauskot, Sonia Poirault-Chassac, Frédéric Adam, et al.Nature Genetics|February 12, 2008
Thromboxane synthase mutations in an increased bone density disorder (Ghosal syndrome)David Geneviève, Valérie Proulle, Bertrand Isidor, et al.Haematologica|March 6, 2025
Increased RhoA pathway activation downstream of αIIbβ3/SRC contributes to heterozygous Bernard Soulier syndromeLarissa Lordier, Christian A Di Buduo, Alexandre Kauskot, et al.Haematologica|March 2, 2019
Relevance of platelet desialylation and thrombocytopenia in type 2B von Willebrand disease: preclinical and clinical evidenceAnnabelle Dupont, Christelle Soukaseum, Mathilde Cheptou, et al.Pageof 4